Literature DB >> 18762486

Pulse oximetry screening at 4 hours of age to detect critical congenital heart defects.

Dorothy M Sendelbach1, Gregory L Jackson, Susanna S Lai, David E Fixler, Elizabeth K Stehel, William D Engle.   

Abstract

OBJECTIVE: The purpose of this prospective study was to assess the feasibility and reliability of pulse oximetry screening to detect critical congenital heart defects in a newborn nursery.
METHODS: The study was performed in a large urban hospital with an exclusively inborn population. Stable neonates who had a gestational age of >or=35 weeks and birth weight of >or=2100 g and in whom a critical congenital heart defect was not suspected were admitted to the newborn nursery. When the 4-hour pulse oximetry reading was <96%, pulse oximetry was repeated at discharge, and when the pulse oximetry reading remained at persistently <96%, echocardiography was performed.
RESULTS: Of 15299 admissions to newborn nursery during the 12-month study period, 15233 (99.6%) neonates were screened with 4-hour pulse oximetry. Pulse oximetry readings were >or=96% for 14374 (94.4%) neonates; 77 were subsequently evaluated before discharge for cardiac defects on the basis of clinical examination. Seventy-six were normal, and 1 had tetralogy of Fallot with discontinuous pulmonary arteries. Pulse oximetry readings at 4 hours were <96% in 859 (5.6%); 768 were rescreened at discharge, and 767 neonates had a pulse oximetry reading at >or=96%. One neonate had persistently low pulse oximetry at discharge; echocardiography was normal. Although 3 neonates with a critical congenital heart defect had a 4-hour pulse oximetry reading of <96%, all developed signs and/or symptoms of a cardiac defect and received a diagnosis on the basis of clinical findings, not screening results.
CONCLUSIONS: All neonates with a critical congenital heart defect were detected clinically, and no cases of critical congenital heart defect were detected by pulse oximetry screening. These results indicate that pulse oximetry screening does not improve detection of critical congenital heart defects above and beyond clinical observation and assessment. Our findings do not support a recommendation for routine pulse oximetry screening in seemingly healthy neonates.

Entities:  

Mesh:

Year:  2008        PMID: 18762486     DOI: 10.1542/peds.2008-0781

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

1.  Results from the New Jersey statewide critical congenital heart defects screening program.

Authors:  Lorraine F Garg; Kim Van Naarden Braun; Mary M Knapp; Terry M Anderson; Robert I Koppel; Daniel Hirsch; Leslie M Beres; Joseph Sweatlock; Richard S Olney; Jill Glidewell; Cynthia F Hinton; Alex R Kemper
Journal:  Pediatrics       Date:  2013-07-15       Impact factor: 7.124

2.  Effectiveness of neonatal pulse oximetry screening for detection of critical congenital heart disease in daily clinical routine--results from a prospective multicenter study.

Authors:  Frank Thomas Riede; Cornelia Wörner; Ingo Dähnert; Andreas Möckel; Martin Kostelka; Peter Schneider
Journal:  Eur J Pediatr       Date:  2010-03-01       Impact factor: 3.183

Review 3.  Pulse oximetry screening for critical congenital heart defects.

Authors:  Maria N Plana; Javier Zamora; Gautham Suresh; Luis Fernandez-Pineda; Shakila Thangaratinam; Andrew K Ewer
Journal:  Cochrane Database Syst Rev       Date:  2018-03-01

4.  Pulse oximetry findings in newborns with antenatally diagnosed congenital heart disease.

Authors:  Isabel E Mawson; Pratusha L Babu; John M Simpson; Grenville F Fox
Journal:  Eur J Pediatr       Date:  2018-02-05       Impact factor: 3.183

Review 5.  A Meta-Analysis about the Screening Role of Pulse Oximetry for Congenital Heart Disease.

Authors:  Caiju Du; Dianmei Liu; Guojing Liu; Huaixin Wang
Journal:  Biomed Res Int       Date:  2017-12-10       Impact factor: 3.411

6.  Pulse Oximetry During the First 24 Hours as a Screening Tool for Congenital Heart Defects.

Authors:  Mihaela Patriciu; Andreea Avasiloaiei; Mihaela Moscalu; Maria Stamatin
Journal:  J Crit Care Med (Targu Mures)       Date:  2017-02-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.